Chemical prevention or reversal of cataract by phase separation inhibitors

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 5401880
SERIAL NO

07817280

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relate to methods and pharmaceutical reagents for decreasing the phase separation temperature and inhibiting the formation of high molecular with aggregates in eye lenses, thereby inhibiting or reversing cataract formation.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
OCULON CORPORATION A CORP OF DELAWARE26 LANDSDOWNE ST STE 470 CAMBRIDGE MA 02139

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Clark, John I Seattle, WA 29 756
Fowler, Kerry W Seattle, WA 53 940
Orme, Mark W Seattle, WA 76 1470
Theodore, Louis J Lynnwood, WA 26 528

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation